News | September 23, 2024
AstraZeneca Pharma India to launch Tremelimumab
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Stable profits, low leverage to keep credit profiles comfortable
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Subscribe To Our Newsletter & Stay Updated
